Nocera, Inc. - common stock (NCRA)
0.9900
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 28th, 4:23 PM EDT
Detailed Quote
Previous Close | 0.9900 |
---|---|
Open | 0.9600 |
Bid | 0.9305 |
Ask | 0.9900 |
Day's Range | 0.9301 - 0.9900 |
52 Week Range | 0.7000 - 2.090 |
Volume | 28,651 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 17,840 |
Chart
About Nocera, Inc. - common stock (NCRA)
Nocera is a biotechnology company focused on developing advanced therapeutic solutions aimed at addressing various medical needs. The company harnesses innovative technologies and scientific research to create novel treatments and drug candidates that target specific diseases and conditions, driving advancements in healthcare. Nocera’s commitment to research and development is central to its mission, as it strives to improve patient outcomes and enhance the overall quality of life through groundbreaking biopharmaceuticals. Read More
News & Press Releases
TAIPEI, TW / ACCESS Newswire / April 28, 2025 / Nocera, Inc., a Nevada corporation (NASDAQ:NCRA) ("Nocera" or the "Company"), a fully integrated sustainable seafood company focusing on manufacturing and operating land-based Recirculatory Aquaculture Systems ("RASs"), today announced that it received a letter from the Nasdaq Stock Market LLC ("Nasdaq") dated April 24, 2025, notifying the Company that, because it has not yet filed its Annual Report on Form 10-K for the year ended December 31, 2024 (the "Form 10-K"), it is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic reports with the Securities and Exchange Commission (the "SEC").
Via ACCESS Newswire · April 28, 2025
Via Benzinga · March 26, 2025
Via Benzinga · March 24, 2025
Via Benzinga · March 24, 2025
Via Benzinga · March 21, 2025

Via Benzinga · January 21, 2025

Via Benzinga · January 16, 2025

Via Benzinga · January 15, 2025

Via Benzinga · December 27, 2024

Via Benzinga · December 26, 2024

Via Benzinga · December 24, 2024

Via Benzinga · October 31, 2024

Via Benzinga · October 30, 2024

Via Benzinga · October 25, 2024

Via Benzinga · October 25, 2024

Via Benzinga · June 12, 2024

Via Benzinga · May 30, 2024

Via Benzinga · May 21, 2024

Via Benzinga · May 21, 2024

Via Benzinga · May 20, 2024

Via Benzinga · April 23, 2024